图片仅供参考，具体产品以实物为准！

MRE-269|10010412-10 mg|CAS:475085-57-5

产品编号

10010412-10 mg

英文名称

MRE-269

标准价

~~¥ 2291.4~~

优惠价

¥ 2291.4

CAS号

475085-57-5

规格

10 mg

有效期

品牌

萘析精选

标准值

见详情

数量

− +

库存

猜您喜欢

3,3''-二硫代二丙酸二(N-羟基丁二酰亚胺)酯[交联剂]|R010186-1g|97%|CAS:57757-57-0
R010186-1g | 1g
2-巯基-4-甲基-5-噻唑乙酸|R010198-10g|98%|CAS:34272-64-5
R010198-10g | 10g
人参皂苷Rg3|CCPE900035|96.9%|25mg|CAS:14197-60-5
CCPE900035 | 25mg
β-萘磺酸钠|R010175-10kg|98%|CAS:532-02-5
R010175-10kg | 10kg
2,3,4-三氟苯酚|R010070-5g|98%|CAS:2822-41-5
R010070-5g | 5g
2,3,4-三氟苯胺|R010071-500g|98%|CAS:3862-73-5
R010071-500g | 500g
5-碘-2-甲基苯胺|R010194-1g|97%|CAS:83863-33-6
R010194-1g | 1g

MRE-269介绍：

产品名称:

MRE-269

别名:

ACT-333679

产品描述:

An IP receptor agonist and active metabolite of NS 304; binds to the IP receptor (Ki = 20 nM); increases cAMP levels in human PASMCs in a concentration-dependent manner; selective for the IP receptor over the DP receptor (IC50 = 2.6 µM), EP1, EP2, EP3, and EP4 receptors (IC50s = >10, 5.8, >10, and 4.9 µM, respectively), FP receptor (IC50 = >10 µM), and TP receptor (IC50 = >10 µM); induces vasodilation equally in both large and small isolated rat pulmonary arteries in a concentration-dependent manner; inhibits ADP-induced platelet aggregation in isolated human and rat platelet-rich plasma (IC50s = 0.21 and 10 µM, respectively); reduces PDGF-induced proliferation of primary patient-derived PASMCs from patients with CTEPH

保存温度:

-20

运输温度:

-20

预期分子量:

419.5

产品形式:

A crystalline solid

有效期:

1460

纯度:

≥98%

CAS号:

475085-57-5

分子式:

C25H29N3O3

本公司销售的所有产品仅供实验科研使用，不用于人体及临床诊断。

暂无标准解读内容

暂无常见问题内容

上一条：MRE-269|10010412-1 mg|CAS:475085-57-5

下一条：MRE-269|10010412-5 mg|CAS:475085-57-5